Receptor-binding determinant from leukaemia inhibitory factor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 6, 2001
Grant Date -
N/A
app pub date -
Sep 27, 1995
filing date -
Feb 3, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates generally to molecules carrying one or more binding determinants for .alpha.-chain of human Leukaemia Inhibitory Factor binding receptor and to genetic sequences encoding same. More particularly, the present invention contemplates a molecule which is non-naturally occurring and which comprises a carrier portion and an active portion and wherein the active portion comprises amino acid residues or chemical equivalents thereof which constitute a binding determinant for the .alpha. chain of the human leukaemia inhibitory factor (hLIF) binding receptor.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully